Eledon Pharmaceuticals Ownership | Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals Ownership Summary

Eledon Pharmaceuticals is owned by 47.27% institutional investors, 1.11% insiders, and 51.62% retail investors. Bvf inc/il is the largest institutional shareholder, holding 8.16% of ELDN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.08% of its assets in Eledon Pharmaceuticals shares.

ELDN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Eledon Pharmaceuticals	47.27%	1.11%	51.62%
Sector	Healthcare Stocks	42.64%	10.86%	46.50%
Industry	Biotech Stocks	45.45%	10.77%	43.78%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	6.29M	8.16%	$16.30M
Vanguard group	4.04M	5.24%	$6.10M
Blackrock funding, inc. /de	3.63M	4.70%	$5.48M
Ra capital management	3.57M	4.62%	$9.24M
Ensign peak advisors	2.46M	3.19%	$3.72M
Blue owl capital lp	1.93M	2.50%	$2.91M
Zimmer partners, lp	1.82M	2.37%	$4.73M
Jefferies financial group	1.58M	2.05%	$2.39M
Geode capital management	1.42M	1.84%	$2.15M
Wellington management group llp	1.28M	1.66%	$3.33M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cm management	650.00K	0.83%	$981.50K
Sphera funds management	1.28M	0.70%	$3.32M
Bvf inc/il	6.29M	0.66%	$16.30M
Catalio capital management, lp	1.06M	0.51%	$2.75M
22nw, lp	636.36K	0.40%	$960.91K
Sanofi	814.98K	0.40%	$1.23M
Exome asset management	114.14K	0.34%	$386.95K
Blue owl capital lp	1.93M	0.22%	$2.91M
Awm investment company	1.10M	0.16%	$1.66M
Ra capital management	3.57M	0.11%	$9.24M

Top Buyers

Holder	Shares	% Assets	Change
Jefferies financial group	1.58M	0.01%	1.58M
Wellington management group llp	1.28M	0.00%	1.28M
Ensign peak advisors	2.46M	0.01%	1.20M
Awm investment company	1.10M	0.16%	1.10M
Catalio capital management, lp	1.06M	0.51%	1.06M

Top Sellers

Holder	Shares	% Assets	Change
First light asset management	-	-	-2.60M
Armistice capital	-	-	-2.36M
Siren	-	-	-2.07M
Frazier life sciences management	-	-	-1.18M
Nantahala capital management	-	-	-1.14M

New Positions

Holder	Shares	% Assets	Change	Value
Jefferies financial group	1.58M	0.01%	1.58M	$2.39M
Catalio capital management, lp	1.06M	0.51%	1.06M	$2.75M
Kovitz investment group partners	732.98K	0.01%	732.98K	$1.90M
Sg americas securities	627.39K	0.00%	627.39K	$947.00K
Inspire investing	194.69K	0.09%	194.69K	$802.12K

Sold Out

Holder	Change
Ifs advisors	-100.00
Srs capital advisors	-152.00
Raymond james financial	-600.00
Jones financial companies lllp	-725.00
Ameritas advisory services	-1.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	87	6.10%	36,469,788	-9.28%	47	1.74%	46	-	20	42.86%
Jun 30, 2025	88	2.33%	40,843,213	6.23%	52	2.13%	48	37.14%	16	-23.81%
Mar 31, 2025	14	-81.82%	17,746,490	-53.88%	29	0.54%	4	-93.75%	4	100.00%
Dec 31, 2024	17	-48.48%	4,377,486	-76.32%	8	0.67%	12	-	-	-100.00%
Sep 30, 2024	33	6.45%	18,485,827	1.24%	35	0.96%	12	-42.86%	6	500.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.84M	3.08%	-40.65K
iShares Russell 2000 ETF	1.38M	2.31%	-
Vanguard US Total Market Shares ETF	1.15M	1.92%	-
Vanguard Institutional Extnd Mkt Idx Tr	669.79K	1.12%	-305.20K
Fidelity Small Cap Index	582.63K	0.97%	582.63K
iShares Russell 2000 Value ETF	476.67K	0.80%	-
Fidelity Extended Market Index	322.60K	0.54%	-2.65K
MEDICAL BioHealth EUR Acc	294.49K	0.49%	-
Vanguard Russell 2000 ETF	278.86K	0.47%	-19.43K
State St Russell Sm Cap® Indx SL Cl I	206.80K	0.35%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$440.49
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$2.10K
Oct 29, 2024	BVF PARTNERS L P/IL	-	Buy	$2.21K
May 09, 2024	BVF PARTNERS L P/IL	-	Buy	$1.95M
May 09, 2024	BVF PARTNERS L P/IL	-	Buy	$232.07

Insider Transactions Trends

Date	Buy	Sell
2035 Q1	-	-
2025 Q1	-	-
2024 Q4	3	-
2024 Q2	6	-
2023 Q4	-	-

ELDN Ownership FAQ

Who Owns Eledon Pharmaceuticals?

Eledon Pharmaceuticals shareholders are primarily institutional investors at 47.27%, followed by 1.11% insiders and 51.62% retail investors. The average institutional ownership in Eledon Pharmaceuticals's industry, Biotech Stocks , is 45.45%, which Eledon Pharmaceuticals exceeds.

Who owns the most shares of Eledon Pharmaceuticals?

Eledon Pharmaceuticals’s largest shareholders are Bvf inc/il (6.29M shares, 8.16%), Vanguard group (4.04M shares, 5.24%), and Blackrock funding, inc. /de (3.63M shares, 4.70%). Together, they hold 18.09% of Eledon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eledon Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eledon Pharmaceuticals.

Who is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Cm management is Eledon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.83% of its assets in 650K Eledon Pharmaceuticals shares, valued at 981.5K$.

Who is the top mutual fund holder of Eledon Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eledon Pharmaceuticals shares, with 3.08% of its total shares outstanding invested in 1.84M Eledon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools